CATALYST PHARMACEUTICALS, INC. - Director's Dealing 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2024-08-09

Reporting Person: INGENITO GARY (Chief Med. & Reg. Officer)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-08-09	Common stock, par value $0.001 per share	M	100000	$4.01	Acquired	151391	Direct
2024-08-09	Common stock, par value $0.001 per share	S	100000	$18.04	Disposed	51391	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-09	Options to purchase common stock	$4.01	M	100000	Disposed	2025-01-02	Common Stock (100000)	Direct

F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.

F2: Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $17.58 to $18.25 per share.

F3: Options vested in three annual tranches beginning on January 2, 2019.